通过表皮生长因子Like-7 (EGFL7) 调节血造干细胞 (HSC) 增殖
bioRxiv : the preprint server for biology
|February 3, 2025
概括
表皮生长因子Like-7 (EGFL7) 促进造血干细胞 (HSC) 的扩张和存活. 这项研究表明,EGFL7对于正常的血液形成至关重要,并增强了压力后的HSC恢复.
科学领域:
- 血液学 血液学 血液学
- 干细胞生物学 干细胞生物学
- 分子生物学分子生物学
背景情况:
- 造血干细胞 (HSC) 生物学对于治疗血液疾病至关重要.
- 长皮生长因子Like-7 (EGFL7) 是一种在成年HSC中高度表达的分泌蛋白质.
研究的目的:
- 研究EGFL7在调节正常血液形成中的作用.
- 为了确定EGFL7是否影响HSC的扩张和生存.
主要方法:
- 使用了EGFL7基因淘汰 (KO) 小鼠和重组EGFL7 (rEGFL7) 蛋白.
- 评估了骨髓细胞性,造血干细胞和原生细胞 (HSPC) 数量以及细胞周期进展.
- 在rEGFL7治疗后评估了HSC扩张和移植潜力.
主要成果:
- Egfl7 KO小鼠表现出骨髓细胞性和HSPCs的减少,这与细胞循环失调和静止性增加有关.
- 在Egfl7 KO小鼠中,rEGFL7治疗挽救了造血缺陷.
- 在野生型小鼠中,rEGFL7的使用增强了基因毒性后应激 (5-FU,辐射) 的HSC扩张,并增加了移植潜力.
结论:
- EGFL7在HSC的扩张和生存中发挥着重要作用.
- EGFL7代表了改善骨髓功能和移植移植的潜在治疗策略.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


